ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

BACH1 as a potential target for immunotherapy in glioblastomas

Yuan, Feng; Cong, Zixiang; Cai, Xiangming; Zhu, Junhao; Yuan, Lei; Wang, Yingshuai; Tang, Chao; Ma, Chiyuan*安徽医科大学; 南方医科大学; 南京大学; 1
International Immunopharmacology2022-2DOI: 10.1016/j.intimp.2021.108451
10被引8阅读
引用收藏
分享

摘要

Glioblastoma (GBM, WHO grade 4) is a highly heterogeneous and aggressive primary malignant brain tumor. BTB domain and CNC homology 1 (BACH1) is a transcription factor, and it plays an essential role in regulating tumor metastasis, tumor metabolism, and tumor stem cell self-renewal. However, its role in glioma is still unclear. In this research, we confirmed that BACH1 as an independent prognostic indicator was enriched in GBMs. BACH1 was strongly correlated with immune responses in GBMs, especially the M0 and M2 tumor-associated macrophage (TAM) mediated immune responses. GBMs with high expression of BACH1 express high levels of immune checkpoints (ICs), glioma cell-derived TAM chemokines, and M2 TAM markers. Interestingly, single cell RNA-seq analysis showed that the expression level of BACH1 in TAMs was higher than that in the other cell types in GBM. Transcriptome analysis of U87-MG cells showed that compared with the BACH1-vector U87-MG group, glioma cell-derived TAM chemokines (including monocyte chemotactic protein-1 (MCP-1), granulocyte-macrophage colony-stimulating factor (GM-CSF), and EGF) and ICs (including CD276, TIM-3, LAG3, TIGIT and LGALS9) were enriched in the BACH1-overexpressing U87-MG group. In addition, we constructed a polygenic risk scoring model and compound nomogram model based on BACH1, which might provide a reliable prognosis assessment tool for clinicians and aid in treatment decision-making in the clinic. In conclusion, this research identified that BACH1 might be a potential molecular signature for survival and immunotherapy response. GBMs with high expression of BACH1 have a stronger immunosuppressive tumor microenvironment (TME). Overexpression of BACH1 can upregulate the expression of glioma cell-derived TAM chemokines and ICs in vitro. Moreover, the risk model and nomogram model based on BACH1 can provide a reliable prognosis assessment tool. Therefore, BACH1 is a promising therapeutic target for GBMs.

学科与关键词

关键词
Glioblastoma (GBM)BTB and CNC homology 1 (BACH1)Transcriptome sequencingTumor microenvironment (TME)Immunotherapy
相关
加载中…
  • A novel chemokine-based signature for prediction of prognosis and therapeutic response in glioma
    Fan, Wenhua; Wang, Di; Li, Guanzhang; Xu, Jianbao; Ren, Changyuan; Sun, Zhiyan; Wang, Zhiliang; Ma, Wenping; Zhao, Zheng; Bao, Zhaoshi; Jiang, Tao*; Zhang, Ying*CNS Neuroscience & Therapeutics, 2022, 28(12): 2090-2103.
  • TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma
    Li, Shasha; Guo, Youwei; Hu, Huijuan; Gao, Na; Yan, Xuejun; Zhou, Quanwei*; Liu, Hui*Frontiers in Immunology, 2023, 14: 1138203.
  • Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
    Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng*Frontiers in Genetics, 2022, 13: 899125.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2022-02
卷期
第 103 卷
页码
108451
DOI
10.1016/j.intimp.2021.108451
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
"333" Project of Jiangsu Province, China [BRA2020417]

作者

  • Y

    Yuan, Feng (第一作者)

    nanjing univ

  • C

    Cong, Zixiang

    nanjing univ

查看全部 8 位作者收起作者
  • C

    Cai, Xiangming

    southeast univ

  • Z

    Zhu, Junhao

    nanjing univ

  • Y

    Yuan, Lei

    1 · anhui med univ

  • W

    Wang, Yingshuai

  • T

    Tang, Chao

    nanjing univ

  • M

    Ma, Chiyuan (通讯)

    southeast univ · nanjing univ · southern med univ · nanjing med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417